Skip to main content
Top
Published in: BMC Infectious Diseases 4/2014

Open Access 01-05-2014 | Poster presentation

Severe sepsis with Hafnia alvei and dual pulmonary infection with Mycobacterium tuberculosis and Pneumocystis carinii in a late presenter patient infected with HIV – case presentation

Authors: Andreea Ardeleanu, Ovidiu Roşca, Monica Cialma, Daniela Desagă, Ingrid Deak

Published in: BMC Infectious Diseases | Special Issue 4/2014

Login to get access

Excerpt

Once thought to be a simple commensal of the gastrointestinal tract, there is increasing evidence to suggest Hafnia alvei is a rare, but significant bacterium that may contribute to opportunistic infections in humans. Bacteremia and respiratory tract infections are the leading extraintestinal manifestations of Hafnia alvei as a pathogen. It can cause disease in immunocompromised patients and it is regularly resistant to multiple drugs. …
Metadata
Title
Severe sepsis with Hafnia alvei and dual pulmonary infection with Mycobacterium tuberculosis and Pneumocystis carinii in a late presenter patient infected with HIV – case presentation
Authors
Andreea Ardeleanu
Ovidiu Roşca
Monica Cialma
Daniela Desagă
Ingrid Deak
Publication date
01-05-2014
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue Special Issue 4/2014
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-14-S4-P21

Other articles of this Special Issue 4/2014

BMC Infectious Diseases 4/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.